Altrius Capital Management Inc Takes $297,000 Position in Axon Enterprise, Inc. (NASDAQ:AXON)

Altrius Capital Management Inc bought a new stake in Axon Enterprise, Inc. (NASDAQ:AXON) in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 500 shares of the biotechnology company’s stock, valued at approximately $297,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the stock. New Wave Wealth Advisors LLC acquired a new position in shares of Axon Enterprise during the fourth quarter valued at about $40,000. Y.D. More Investments Ltd purchased a new position in shares of Axon Enterprise in the fourth quarter worth about $45,000. Prestige Wealth Management Group LLC increased its position in shares of Axon Enterprise by 115.8% in the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company’s stock valued at $33,000 after acquiring an additional 44 shares during the period. Stonebridge Financial Group LLC purchased a new stake in Axon Enterprise in the fourth quarter worth $53,000. Finally, GPS Wealth Strategies Group LLC grew its stake in Axon Enterprise by 74.1% in the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company’s stock worth $56,000 after purchasing an additional 40 shares during the period. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms recently commented on AXON. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a “buy” rating and a $700.00 price objective on the stock. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a report on Monday, January 27th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Needham & Company LLC reiterated a “buy” rating and issued a $600.00 price objective on shares of Axon Enterprise in a research report on Wednesday. Finally, Craig Hallum lowered shares of Axon Enterprise from a “buy” rating to a “hold” rating and set a $625.00 price target on the stock. in a research report on Thursday, February 20th. Three equities research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $587.38.

Axon Enterprise Price Performance

NASDAQ:AXON opened at $525.63 on Friday. The firm has a market cap of $40.08 billion, a PE ratio of 135.82, a price-to-earnings-growth ratio of 5.17 and a beta of 1.05. Axon Enterprise, Inc. has a 12 month low of $273.52 and a 12 month high of $715.99. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The company’s 50-day moving average price is $611.62 and its two-hundred day moving average price is $522.09.

Insider Transactions at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the sale, the director now owns 6,929 shares of the company’s stock, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Julie A. Cullivan sold 1,261 shares of the stock in a transaction dated Wednesday, December 4th. The stock was sold at an average price of $682.06, for a total transaction of $860,077.66. Following the sale, the director now owns 2,392 shares in the company, valued at $1,631,487.52. The trade was a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 8,711 shares of company stock worth $5,631,561. 5.70% of the stock is currently owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.